An 80-year-old woman with a recent diagnosis of invasive mammary carcinoma was found to have a left thyroid mass during routine physical examination. There was no previous exposure to ionizing radiation or known family history of thyroid cancer. Laboratory testing showed a normal TSH along with thyroid auto-antibodies. Ultrasound identified a mass measuring up to 4.0 cm. No cervical lymphadenopathy was detected. A fine-needle aspiration biopsy was performed at an outside institution. Subsequently, the patient was referred for diagnostic left hemithyroidectomy.What Is Your Diagnosis? Figures 1, 2, 3, and 4.Clinicopathological Diagnosis Metastatic renal cell carcinoma within an infiltrative follicular variant papillary thyroid carcinoma.Gross examination of the specimen confirmed a 4.0-cm tan-brown, encapsulated solid nodule with areas of hemorrhage and cystic degeneration (Fig. 1). On histological examination, the tumor displayed follicular (30 %) and solid (70 %) architecture ( Fig. 1). While the component with conventional follicular architecture displayed nuclear features of papillary thyroid carcinoma characterized by nuclear membrane irregularities and chromatin margination in enlarged nuclei, areas with solid growth had relatively smaller nuclei with nuclear membrane irregularities (Fig. 2). The solid component exhibited variable clear cell change as well as scattered follicle-like structures with a central core rich in red blood cells leading to an appearance of Bbloody follicles^ (Fig. 2). Scattered abortive papillary structures lacking true fibrovascular cores and histiocytic infiltrate were seen in the solid region (Fig. 2). No evidence of necrosis was noted. The mitotic count was less than 3 per 10 high-power fields. Cystic change was closely associated with fine-needle aspiration-related changes. There was evidence of multifocal transcapsular invasion associated with both solid and follicular architecture (Fig. 3). No evidence of extra-thyroidal extension, lymphatic invasion, or vascular invasion was found in the submitted sections. The conventional follicular component was positive for PAX8, TTF-1, and thyroglobulin, whereas the solid areas were negative for TTF-1 and thyroglobulin, and were positive for PAX8 (Fig. 4). Both regions were negative for GATA-3, parathyroid hormone, chromogranin-A, monoclonal CEA, and calcitonin. Vimentin was expressed throughout the tumor (Fig. 4). CD10 expression was prominent in the solid component (Fig. 4), but weak and patchy staining was also noted in the conventional follicular component. Positivity for PAX8, CD10, and vimentin along with negativity for TTF-1 and thyroglobulin in the solid component confirmed the diagnosis of metastatic renal cell carcinoma within an infiltrative follicular variant papillary carcinoma was rendered. Subsequently, we were informed that the patient had undergone radical nephrectomy 18 years ago for renal cell carcinoma.